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Transforming growth factor beta
T-lymphocytes
T-lymphocytes, regulatoryChildren with acute RV-gastroenteritis (GE) had low or undetectable levels of circulating IFN-γ+, IL-13+,
IL-2+, IL-10+ or IL-17+ RV-T cells. IFN-γ+ T cells and low frequencies of IL-10+ and IL-2+ CD4+ T cells were
found in adults with RV-GE during acute and convalescence phases, respectively. Circulating single
IFN-γ+Ndouble IFN-γ+/IL-2+Nsingle IL-2+RV-CD4+T cells were observed in healthy adults. In this group,
frequencies of IFN-γ+ RV-T cells increased after removing CD25+cells, blocking TGF-β with its natural
inhibitor, LAP, or inhibiting TGF-βRI signalling pathway with ALK5i. The frequencies of IFN-γ+ RV-T cells
were also incremented in PBMC depleted of CD25+cells and treated with ALK5i, suggesting that TGFβ
inhibition may be independent of Treg cells. The ALK5i effect was observed in adults but not in children with
RV-GE, who had normal numbers of TGF-β+ Treg cells. Thus, a TGF-β-mediated regulatory mechanism that
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Every year, (RV) cause approximately 111 million episodes of
gastroenteritis (GE) and 611,000 (range 454,000–705,000) deaths in
children younger than 5 years of age worldwide, 1800 of which are
estimated to occur in Colombia (Parashar et al., 2006). Advances in
our knowledge of the mechanisms that mediate immunity against RV
are needed to improve current RV vaccines and/or to develop new RV
vaccines (Angel et al., 2007; Franco et al., 2006). Understanding the
antiviral T cell response is critical for this purpose, because protective
antibodies against RV are T cell dependent and T cells also mediate
effector immunity (Angel et al., 2007; Franco et al., 2006).
In the past we have found that both healthy and RV-infected
adults have relatively low frequencies of circulating RV-speciﬁc CD4+
and CD8+ T (RV-CD4+ and RV-CD8+) cells that secrete interferon
gamma (IFN-γ), but not IL-13 or IL-4 (Jaimes et al., 2002; Rojas et al.,
2003); also, IL-2+ and IL-10+ CD4+ RV-T cells were variably presentand absent, respectively, in a small subset of healthy adult volunteers
studied (Narvaez et al., 2005). In children with RV GE, the number of
RV-CD4+ T cells that secrete IFN-γ, IL-13 or IL-4 and CD8+ that
secrete IFN-γ or IL-4 are even lower or undetectable (Jaimes et al.,
2002; Rojas et al., 2003). The low frequencies of RV-T cells could be
explained by the following hypothesis: (1) RV triggers speciﬁc T cells
that secrete cytokines not yet evaluated (Jaimes et al., 2002). (2) In
children, the low frequency of RV-T cells could reﬂect low numbers
of T lymphocytes, since absolute lymphopenia (≤2,900/μl) and low
percentages of CD4+ and CD8+ T cells, but not B cells, were described
in the acute phase in 5/7 of children with RV GE (Wang et al., 2007).
(3) RV infection could induce the generation of regulatory T cells
(Treg cells). In support of this last hypothesis, it has been shown that
Treg cells can suppress T cell responses against RV in mice (Kim et al.,
2008), and T cell responses during acute infection with a non
persistent virus like dengue in humans (Luhn et al., 2007). For RV,
this hypothesis gains particular relevance since intestinal dendritic
cells (most probably the ﬁrst antigen presenting cell [APC] to handle
the virus) from mice (Coombes et al., 2007; Sun et al., 2007) and
humans (Rimoldi et al., 2005) are prone to induce anti-inﬂammatory
immune responses and inmice promote de novo generation of FoxP3+
Treg cells through mechanisms involving Transforming Growth
Factor-beta (TGF-β) and retinoic acid (Coombes et al., 2007; Sun
et al., 2007).
78 M.C. Mesa et al. / Virology 399 (2010) 77–86Here we tested these three hypotheses by determining: (1) The
frequencies of circulating RV-CD4+ and CD8+ T cells that secrete
IFN-γ, IL-13, IL-2, IL-10 or IL-17 in children and adults with or
without RV GE. (2) The relative and absolute numbers of circulating
leukocytes, lymphocytes and Treg cells from children with acute RV
GE. (3) The frequencies of circulating IFN-γ+ RV-CD4+ and CD8+
T cells after removal of Treg cells (CD25+ cells) or inhibition of their
TGF-β dependent function by two approaches: blocking TGF-β with
its natural inhibitor LAP, or inhibiting the signalling pathway of the
TGF-β receptor TGF-βRI/ALK5 with the synthetic inhibitor SB431542
(ALK5i).
Results
Frequencies of RV-T cells in healthy adults and adults with RV GE
Of the cytokine producing T cells evaluated in healthy adults
volunteers, only RV-speciﬁc IFN-γ+ and IL-2+ CD4+ T cells were
detected in 14/21 (66.7%) and 6/10 (60%) individuals, respectively, at
frequencies≤0.65% (Fig. 1A). IFN-γ+ and IL-2+ RV-CD8+ T cells were
observed in 8/20 (40%) and 1/9 healthy adult volunteers, respectively
(Fig. 1B). The analysis of multifunctional RV-speciﬁc T cells (produc-
ing simultaneously more than one cytokine), in a subset of healthy
adult volunteers from Fig. 1, showed that the majority of RV-CD4+
T cells produce only IFN-γ and that most of the IL-2+ RV-CD4+ cells
were simultaneously secreting IFN-γ (Fig. 2A). In contrast, for SEB-
stimulated PBMC, the CD4+ T cells were mostly single IL-2+ followed
by the IFN-γ+ and IL-2+ double positive cells (IFN-γ+/IL-2+) and
single IFN-γ+ cells (Fig. 2C). For both, RV- and SEB-CD8+ T cells, single
IFN-γ+ were the predominant population, followed by single IL-2+
and IFN-γ+/IL-2 cells (Figs. 2B, D). Thus, compared to SEB stimulated
cells, the proﬁle of IFN-γ+ and IL-2+ RV-CD4+ is different and that
of CD8+ is similar. RV speciﬁc CD4+ and CD8+ IL-10+ (Figs. 1A–B),
IL-13+ or IL-17+ (data not shown) were not detected in 6–7 healthy
adult volunteers.
In 4/4 adults with acute RV GE, IFN-γ+ and IL-10+ RV-CD4+ T cells
were found at higher percentages (P=0.016 and P=0.009, respec-
tively; Mann–Whitney tests) than those detected in healthy volun-
teers and IL-2+were not detected in 3/3 patients (Fig. 1A). During the
convalescence phase, IFN-γ+ RV-CD4+ T cells were detected in 5/5,Fig. 1. Frequencies of RV-speciﬁc CD4+ and CD8+ T cells in healthy adult and adults with a
convalescence phase (C) were cultured with RRV (MOI:7) or mock in the presence of anti-CD
and IL-10 producing T cells were evaluated by ICS and ﬂow cytometry. (A) CD4+ and (B) CD
represents the limit detection. ⁎Pb0.05; Mann–Whitney test.IL-10+were undetectable in the four patients studied and IL-2+ CD4+
T cells were present in 3/5 patients (Fig. 1A). RV-CD8+ IFN-γ+, IL-2+
and IL-10+ T cells were seen in 2/3, 0/3 and 1/3 patients with acute
RV GE (Fig. 1B) respectively, and during the convalescence phase only
2/3 secreted IFN-γ+ (Fig. 1B). Cells stimulated with SEB were used as
a positive control in all experiments, and the expected frequencies of
cytokines producing CD4+ and CD8+ T cells (Table S2) were found
(Jaimes et al., 2002).
Groups of children studied
Three groups of children with GE were studied: group A, children
without evidence of previous RV infection (plasma RV-IgA−) and
without RV GE (n=15); group B, children with evidence of previous
RV infection (plasma RV-IgA+) but without RV GE (n=21), and group
C children with RV GE (n=17). Demographic and clinical data of
these children are summarized in supplemental material Table S1.
Boys were more frequent than girls in groups A and C (P=0.010 and
0.016 respectively; chi square test). The days after onset of diarrhea
(DAOD) were lower in children from group C compared to children
from groups A and B (P=0.010; Kruskall–Wallis test; P=0.018 and
P=0.004, respectively; Mann–Whitney tests). No differences were
observed in age (P=0.263; Kruskall–Wallis test), the Ruuska–
Vesikari score (P=0.844; Kruskall–Wallis test) or breast feeding
among the three groups (PN0.05; chi square test). When children
without RV GE from A and B groups were combined (group A+B),
and compared to group C, children with RV GE, the latter had lower
DAOD (P=0.024; Mann–Whitney test). Differences in gender, the
Ruuska–Vesikari score and breast feeding between groups A+B and C
were not signiﬁcant.
Circulating IL-2+, IL-10+ or IL-17+ RV-CD4+ and CD8+ T cells are low
or absent in peripheral blood from children with acute GE
In children with acute GE, from groups A, B and C, the frequencies
of circulating IFN-γ+, IL-13+, IL-2+, IL-10+ and IL-17+RV-CD4+
T cells were low (b0.06) in few children or absent in the majority, and
no statistical differences were seen between the three groups (Fig. 3).
Only 2/12 children from each group B and C had IFN-γ+RV-CD4+
T cells (Fig. 3). RV-CD8+ T cells were studied in a subset of children ofcute RV GE. PBMCs from healthy adults (H) and adults with RV GE during acute (A) or
28 and anti-CD49d MAbs for 10 h; brefeldin A was added during the last 5 h. IFN-γ, IL-2
8+ RV-speciﬁc T cells are shown as net percentages (RRV minus mock). The dotted line
Fig. 2. Frequencies of RV and SEB-speciﬁc multifunctional IFN-γ+/IL-2+ CD4+ and CD8+ T cells in healthy adult volunteers. PBMC were cultured with RRV (MOI:7), mock or SEB, in
the presence of anti-CD28 and anti-CD49dMAbs for 10 h; brefeldin Awas added during the last 5 h. IFN-γ and IL-2 were evaluated in CD4+ and CD8+ cells by ICS and ﬂow cytometry.
Using boolean gates, the frequencies of CD4+ and CD8+ T cells secreting total IFN-γ (t-IFNγ+), total IL-2 (t-IL2+), only IFN-γ+ (s-IFNγ+), only IL-2+ (s-IL2+) or both cytokines
(d-IFNγ+/IL2+) were evaluated. (A–B) RV-CD4+ and CD8+ T cells: Net percentages (RRV minus mock) values are shown. (C–D) SEB-stimulated CD4+ and CD8+ T cells. The dotted
line represents the limit detection. ⁎ Pb0.05; Wilcoxon test.
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RV-CD8+ T cells (data not shown). These ﬁndings suggest that few
children with GE and past (group B) or present (group C) RV infection
have circulating RV-T cells. Expected frequencies of IFN-γ+, IL-13+,
IL-2+, IL-10+ or IL-17+ CD4+ and CD8+ T cells were observed in
response to the polyclonal stimulus with SEB (Jaimes et al., 2002),
with similar values in the three study groups (Table S3).
T cell lymphopenia is observed in a subset of children with acute RV GE
Lymphopenia has been described in a subset of childrenwith acute
RV GE (Wang et al., 2007). To determine if lymphopenia (b2900
lymphocytes/μl) could be related to the low numbers of RV-T cells, weFig. 3. Frequencies of RV-CD4+ T cells secreting cytokines in children with acute GE. PBMC
presence of anti-CD28 and anti-CD49d MAbs for 10 h; brefeldin A was added during the la
evaluated by ICS and ﬂow cytometry. Net percentages (RRV minus mock) values are showndetermined absolute lymphocyte counts in children. We found
absolute lymphopenia in 5/12 (41.6%) children with RV acute GE
(Group C) and only in 1/25 from group A+B (Pb0.01; Fisher exact
test) (Fig. 4). The frequencies of CD3+, CD4+ and CD8+ were
comparable between groups A+B and C (Fig. 4). No differences
were observed for numbers of leukocytes, neutrophils or monocytes
between groups A+B vs. C (Fig. 4).
Depletion of CD25+ cells from PBMC of healthy adult increases the
frequency of RV-T cells
To explore the role of CD25+ Treg cells on the RV-T cell response,
the frequency of RV-speciﬁc IFN-γ+ T cells was evaluated in CD25+-from children from groups A, B and C, were cultured with RRV (MOI:7) or mock in the
st 5 h. Frequencies of IFN-γ, IL-13, IL-12, IL-10 and IL-17 producing CD4+ T cells were
. The dotted line represents the limit detection.
Fig. 4. Absolute counts for peripheral blood leukocytes subsets in children with acute GE. Absolute counts for total leukocytes, lymphocytes, neutrophils and monocytes from
children from groups A, B and C, were obtained from electronic analyzers. Frequencies of CD3+, CD3+CD4+ and CD3+CD8+ T cells were determined by ﬂow cytometry. Absolute
values for CD3+, CD3+CD4+ and CD3+CD8+ subsets were estimated from absolute lymphocyte counts. The dotted lines limit the region of reference values for children under
2 years (Shearer et al., 2003).
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frequency of IFN-γ+ RV-CD4+ lymphocytes was signiﬁcantly
(P=0.0053, Wilcoxon test; n=13) higher after removing CD25+
cells (Fig. 5A). For RV-CD8+ lymphocytes, the results were not
signiﬁcant but 4/13 volunteers showed increments in the percentage
of IFN-γ+ RV-CD8+ cells after CD25+ cell depletion (Fig. 5B).
A comparable (not statistically signiﬁcant) trend was observed for
CD4+ and CD8+ T cells in similar experiments using humanWa strain
RV (n=5; data not shown). Cultures with polyclonal SEB stimulus
showed small but not signiﬁcant increments in percentages of IFN-γ+
CD4+ and CD8+ lymphocytes in 8/13 healthy volunteers (Fig. S1A–B).
Thus, in healthy adult volunteers, the IFN-γ+ memory T cell response
against RV is modulated by CD25+ cells.
TGF-β modulates RV-T cells in healthy adults
One of the mechanisms that CD25+ and CD25– Treg cells use
for their regulatory function involves membrane bound TGF-β
(Nakamura et al., 2004). To determine if TGF-β modulates the RV T
cell response, T cells were stimulated with RV in the presence or
absence of its natural inhibitor rhLAP, which can reverse the
suppression exerted by TGF-β dependent Treg cells (Nakamura et al.,
2004). Signiﬁcantly higher percentages of IFN-γ+ RV-CD4+ and CD8+
lymphocytes were observed in the presence of rhLAP (Fig. 5C–D). The
treatment with rhLAP also increased the frequencies of IFN-γ+ T cells
in PBMC cultures stimulated with SEB (Fig. S1C–D). In similar cultures
(n=3) stimulatedwith the humanWa RV strain, rhLAP also increased
the frequencies of IFN-γ+ CD4+ and CD8+ T cells (data not shown). To
further clarify the role of TGF-β in modulating RV-T cells, PBMC were
preincubatedwith andwithout SB431542 (ALK5i, a synthetic inhibitor
of the intracellular signalling of the TGF-β receptor) (Oida et al., 2006)
before stimulation with RV. Signiﬁcant increments in the frequencies
of IFN-γ+ RV CD4+ (P=0.005, Wilcoxon test; n=11) and in IFN-γ+RV CD8+ (P=0.008, Wilcoxon test; n=11) T cells were observed in
cultures of PBMC treated with the ALK5i (Fig. 5E–F). A similar trend
was observed in response to SEB (Fig. S1E–F). To determine if the
TGF-β was derived from CD25+ Treg cells (Laouar et al., 2005), the
frequencies of IFN-γ+ RV-T cells were evaluated after simultaneous
CD25+ cell depletion and treatmentwith ALK5i. Percentages of IFN-γ+
CD4+ and CD8+ were increased in cultures both depleted of CD25+
cells and treated with ALK5i, compared to only CD25+ depleted and
only ALK5i treated cells, inmost (5/8) volunteers (Fig. 5G–H). Variable
results were observed with SEB stimulated cells (Fig. S1G–H). Thus,
the IFN-γ+ RV-memory T cell response in healthy adults may be
regulated by CD25+ Treg cells by a TGF-β independent mechanism,
and also by TGF-β, independently of CD25+ Treg cells.
TGF-β modulates the RV-T cell response in adults but not in children
with acute RV GE
To evaluate if the TGF-β-dependent regulatory mechanism
modulates RV-T cells of adults and children with RV GE, their RV-T
cellswere studied in the presence or not of ALK5i. In adults in acute and
convalescence phases of RV GE, the frequencies of IFN-γ+ RV-CD4+
were higher in the presence of ALK5i in 4 volunteers studied (Fig. 6A).
A similar trend was observed for IFN-γ+ RV-CD8+ T cells in 3
individuals (Fig. 6B). Incrementswere also observed in response to SEB
for both CD4+ and CD8+ lymphocytes during the acute and
convalescence phases (Fig. S2A–B). In children from groups A, B and
C, no increments in the frequencies of IFN-γ+ RV-CD4+ T cells were
observed in the presence of ALK5i (Fig. 6C). A signiﬁcant increment
was observed in the frequency of IFN-γ+ CD4+ lymphocytes in
response to SEB in children from group A and A+B (P=0.016 and
P=0.012, respectively; Wilcoxon tests) but not in children from
groups B and C (Fig. S2C). The frequencies of IL-2+, IL-13+ or IL-10+
RV-CD4+ T cells were not increased after ALK5i treatment of cells from
Fig. 5. CD25+ Treg cells and a TGFβ-mediatedmechanismmodulate RV-T responses in healthy adults. Total PBMCor PBMCwith different treatments (see below)were stimulatedwith
RRV (MOI:7) or mock in the presence of anti-CD28 and anti-CD49dMAbs for 10 h; brefeldin A was added during the last 5 h. CD4+ and CD8+ IFN-γ+ T cells were quantiﬁed using ICS
and ﬂow cytometry. Net percentages (RRV minus mock) of IFN-γ+ lymphocytes are shown. (A, B) PBMC without CD25+ cells. (C, D) PBMC exposed to LAP for 10 min prior to
stimulation. (E–F) PBMC exposed to ALK5i for 30 min prior to stimulation. (G, H) PBMC exposed to ALK5i or CD25+ cells depletion or both treatments simultaneously prior to
stimulation. (A, C, E andG) Percentages of IFN-γ+CD4+T cells. (B, D, F andH) Percentages of IFN-γ+CD8+T cells. The dotted line represents the limit detection. ⁎Pb0.05;Wilcoxon test.
81M.C. Mesa et al. / Virology 399 (2010) 77–86GE-affected adults or children (data not shown). These results suggest
that the TGF-β dependent regulatory mechanism that modulates
IFN-γ+ RV-T cells becomes evident with age, being apparent in adults
but not childrenwithpresent (groupC) or past (groupB) RV infections.
Numbers of circulating CD4+, CD25+, LAP+ (TGF-β+) Treg cells are
comparable in children with RV or non-RV GE
To determine if the absence of the regulatory-TGF-β dependent
mechanism in children, described above, was related to a diminishedfrequency of their circulating Treg cells, the relative and absolute
frequencies of circulating CD4+CD25+ (themost frequently evaluated
subset of Treg cells) (Sakaguchi et al., 2006), CD4+CD25+CD127low
(a subset equivalent to classical FoxP3+ Treg cells) (Seddiki et al.,
2006) and CD4+CD25+CD127lowLAP+ (Treg cells that express surface
TGF-β) (Ito et al., 2008) T cells were quantiﬁed (Fig. 7 and S3). All Treg
cells subsets were observed in peripheral blood from children with
acute RV GE with relative and absolute counts similar to those from
children with non-RV acute GE (Fig. 7). CD45RA was expressed in
most of the CD4+CD25+CD127low Treg cells and in approximately 40%
Fig. 6. ALK5i increases the frequencies of RV- IFN-γ+ CD4+ and CD8+ lymphocytes in adults but not in children with RV GE. (A, B) PBMC drawn from adults with acute RV GE during
acute and convalescence phases; and (C) PBMC from children from groups A and B and C were exposed or not to ALK5i for 30 min prior to adding RRV (MOI=7) or mock in the
presence of anti-CD28 and anti-CD49d MAbs for 10 h. Brefeldin A was added during the last 5 h. IFN-γ+ lymphocytes were evaluated using ICS and ﬂow cytometry. Net percentages
(RRVminus mock) of IFN-γ+ CD4+ lymphocytes (A) and CD8+ lymphocytes (B) from adults and IFN-γ+ CD4+ lymphocytes from children (C) are shown. The dotted line represents
the limit detection.
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Treg cells are present in the peripheral blood from childrenwith RVGE
with frequencies similar to those detected in childrenwith non-RVGE ,
this cytokine is not responsible for the low frequency of IFN-γ+
RV-CD4+ T cells detected in short term cultures of PBMC from children
with acute RV GE.
Discussion
We have extended our previous studies to show that, like for
IFN-γ, IL-13 and IL-4 (Jaimes et al., 2002; Rojas et al., 2003), very few
or no IL-2+, IL-10+, IL-17+ RV-CD4+ and CD8+ T cells circulate in
children with acute RV GE (Fig. 3 and data not shown). In healthy
adults, most RV-CD4+ cells secrete INF-γ, few secrete simultaneously
IFN-γ and IL-2 and none IL-2 alone (Fig. 2A). In adults with acute RV
GE, low levels of IL-10+ and IL-2+ RV-CD4+ cells were found during
acute and convalescence phases, respectively (Fig. 1A). In adults, the
IFN-γ+ RV-CD4+ and in some cases CD8+ T cell response is partially
regulated by CD25+ T cells (Fig. 5A–B) and independently by a TGF-β-
dependent mechanism (Fig. 5G–H); such mechanism is not observed
in children with past or present RV infection (Fig. 6C).
As previously noted (Jaimes et al., 2002; Rojas et al., 2003), the
frequency of IFN-γ+ RV-CD4+ and -CD8+ T cells in acutely infected
adults (Fig. 1A–B) is much lower than in patients with acute EBV
(Amyes et al., 2003; Hoshino et al., 1999), and CMV (Harari et al.,
2005; Lidehall et al., 2005) which are accompanied by important
viremia, and where virus speciﬁc CD8+ T cells can be as high as 60% of
blood T cells. Unlike for children (Table S1), we have not detected
antigenemia in RV infected adults (data not shown). Thus, the
frequencies of IFN-γ+ RV-CD4+ and CD8+ T cells in adults with acute
RV GE, may be lower because important systemic dissemination of
virus does not take place. The frequencies of RV IFN-γ+-CD4+ and
-CD8+ T cells circulating in healthy adults (Fig. 1A–B) although
present only in a subset of volunteers (66,7% and 40% for CD4+ andCD8+ T cells, respectively) in general are comparable to those speciﬁc
for some non mucosal viruses (Harari et al., 2005; Nanan et al., 2000),
and to responses to several mucosal respiratory viruses (de Bree et al.,
2007; Heidema et al., 2008; Kannanganat et al., 2007; Tilton et al.,
2007).
IL-2hasbeenpreviously shown in supernatants of PBMCstimulated
with RV from healthy adults but not cord blood (Mesa et al., 2007;
Yasukawa, Nakagomi, and Kobayashi, 1990). Also, IL-2 is produced by
CD4+ T cells stimulated with RV-exposed mDC in 2 of 4 healthy
volunteers studied (Narvaez et al., 2005). Here we showed that
RV-CD4+T cells fromhealthy adults predominantly secrete IFN-γ, very
few secrete both IFN-γ and IL-2, (the latter only in 55% of volunteers),
and cells secreting only IL-2 are not detectable (Fig. 2A). RV IL-2+CD4+
T cells were evidenced during the convalescence phase in 3/5 adults
with RV GE but not in 3/3 adults studied during the acute phase
(Fig. 1A). Contrary to RV but similar to SEB (Fig. 2A, C), IL-2+ or
IFN-γ+IL-2+ double producers CD4+ T cells are more frequent than
IFN-γ+ single producer in response to viruses that are efﬁciently
cleared (vaccinia and inﬂuenza) (Harari et al., 2005; Kannanganat
et al., 2007; Tilton et al., 2007). The same is true, but to a lower degree,
with viruses that generate persistent infections but relatively low
levels of circulating antigen (CMV, EBV) (Harari et al., 2005;
Kannanganat et al., 2007; Tilton et al., 2007). The presence of a
dominant single IFN-γ+ CD4+ T cell response, like we observe for RV
(Fig. 2A), has been associated with chronic infections with persistent
antigen (HIV, HCV) and in response to non protective vaccines (Harari
et al., 2005; Seder et al., 2008). Thus, the lack of circulating IFN-γ+/
IL-2+ RV-CD4+ T cells in approximately 40% of healthy adults (Fig. 2A)
and 3/3 adults with RV GE (Fig. 1A) could be related to a higher
susceptibility to RV infection. In the convalescence phase, the IL-2+
RV-CD4+ subset was detected in 3/5 subjects examined, suggesting
that these cells appear upon multiple infections.
RV-CD4+ T cells from adults with RV GE secrete IL-10 during
acute phase, but not during the convalescence phase after infection
Fig. 7. Relative and absolute counts of Treg cells subsets in children with acute GE. Relative (A, C, E) and absolute (B, D, F) numbers of Treg cells subpopulations were determined in
PBMC from children with acute GE from groups A+B (circles) and C (diamonds). The cells were stained following protocol 1 (open symbols) or protocol 2 (ﬁlled symbols), described
in Materials and methods and analyzed as described in Fig. S3A or S3B. Stain 1 and Stain 2 include polyclonal and MAbs against LAP, respectively (described in Materials and
methods). Subpopulations of Treg cells were deﬁned as (A, B) CD4+CD25+, (C, D) CD4+CD25+CD127low and (E, F) CD4+CD25+ CD127lowLAP+. Absolute counts were estimated
based on lymphocyte numbers from Fig. 4. Similar results to those shown for CD4+CD25+ cells (upper row)were obtained upon analysis of CD4+ CD25hi cells (data not shown). Bars
represent median values.
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T cells, IL-10 is produced by Th1 (Del Prete et al., 1993; Jankovic et al.,
2007; O'Garra and Vieira, 2007) and Th2 (Street and Mosmann, 1991)
effector cells, and natural (Asseman et al., 1999; Ito et al., 2008) and
adaptive Tr1 Treg cells (Groux et al., 1997; Roncarolo et al., 2006). To
establish, whether Th1, Tr1 or other subsets of RV CD4+ T cells are the
IL-10 producing cells in adults with acute RV GE (Fig. 1A) will require
additional studies.
In contrast to the ﬁndings in adults, only very few childrenwith RV
GE had low levels of IFN-γ+, IL-2+ or IL-10+ RV-CD4+ T cells and
none had IL-17+ cells (Fig. 3A). Having broadened our panel of
cytokines to evaluate RV-T cells, it seems unlikely that, as previously
proposed (Jaimes et al., 2002), the low frequencies of RV-T cells
observed in children are due to the fact that they secrete other
cytokines than those analyzed. Moreover, a general dysfunction of
T cells during RV GE also does not seem a complete explanation for
this phenomenon, since SEB responses in children with RV GE were
comparable to children without RV GE (Table S3). In addition,
although we found absolute lymphopenia in 5/12 (41.6%) children
with acute RV GE (Fig. 4), a somewhat lower value than that
previously reported 5/7 (Wang et al., 2007), low frequencies of RV
IFN-γ+ CD4+ T cells were equally observed in children with low or
normal absolute counts of lymphocytes (data not shown).
The removal of CD25+ cells revealed a higher frequency of IFN-γ+
RV-CD4+ T cells in most healthy adults analyzed and of IFN-γ+ RV-
CD8+ T cells in some of them (Fig. 5A), suggesting that CD25+ Treg
cells control the RV-T cells. This ﬁnding is in agreement with the fact
that in RV infected mice CD4+ CD25+ cells suppress speciﬁc and non-speciﬁc B and T cells responses after the virus clearance (Kim et al.,
2008). The absence of any increment in IFN-γ+ RV-T from some
healthy volunteers could be related to the removal of recently
activated CD25+ effector T cells or to a lack of recent RV stimulation.
The CD25+ and CD25- Treg cells could be mediating their function
through mechanisms that involve membrane bound or soluble TGF-β
(Nakamura et al., 2004), soluble IL-10 (Sun et al., 2007; Vieira and
O'Garra, 2007) or other molecules (Vignali et al., 2008). In our model,
PBMC from most volunteers depleted of CD25+ cells and also treated
simultaneously with ALK5i had higher frequencies of RV-CD4+ and
CD8+ T cells than PBMC with CD25+ cells depletion or ALK5i
treatment alone (Fig. 5G–H), suggesting that the TGF-β is derived
from cells other than CD25+ Treg cells. As previously suggested, the
variability in the T cell response among healthy volunteers could be
related to differences in recent RV exposure. The CD25+ independent
source of TGF-β in our studies could potentially be CD25- Treg cells,
and specially monocytes, most of which express membrane bound
LAP (data not shown).
Contrary to adults, TGF-β is not involved in modulating RV-T cells
in children (Fig. 6C). However, CD4+CD25+CD127lowLAP+ Treg cells
were observed in peripheral blood of all children studied (Fig. 7E–F)
suggesting that, although present, they are not involved in a TGF-β–
mediated regulation of peripheral RV-T cells. To our knowledge,
absolute values of Treg cells have not been previously reported in
young (b2 year old) children and few studies have addressed relative
frequencies of Treg cells subpopulations (Fuchizawa et al., 2007).
However, the relative percentage of CD4+CD25+ and probably
CD4+CD25+CD127low T cells (the latter is equivalent to FoxP3+
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those reported for the same age group in healthy children, suggesting
that GE, and RV GE in particular, do not change the frequencies of
these peripheral Treg cells (Fuchizawa et al., 2007).
It is possible that although Treg cells are present, they cannot
perform their function in our assay in children. In support of this
hypothesis, depletion of CD25+ Treg cells from 7- to 25-month-old
HIV infected and exposed infants did not increase the frequency of HIV
speciﬁc T cells (Legrand et al., 2006). In addition, in similar studies ofN.
meningitidis speciﬁc T cells, CD25+ Treg cells are not apparent in 2- to
7-year-old children, but are detectable in children older than 8 years
and at higher levels in adults (Davenport et al., 2007). These ﬁndings
could be related to immaturity of Treg from children. In fact, some
studies, but not others, have shown that, compared to circulating Treg
cells from adults, cord blood Treg cells do not modulate effector T cell
responses to mitogens (Fritzsching et al., 2006; Takahata et al., 2004),
alloAg (Santner-Nanan et al., 2008; Thornton et al., 2004; Wing et al.,
2005), auto-Ags and foreign Ags (Brustoski et al., 2006; Legrand et al.,
2006;Wing et al., 2005). Cord bloodTreg cells are phenotypically naive
(CD45RA+ CD38+), while adult Treg cells have a memory phenotype
(CD45RO+ HLA-DR+) (Takahata et al., 2004; Wing et al., 2002) and
when naive CD45RA+ Treg cells from cord blood and peripheral blood
from adults (Fritzsching et al., 2006) are compared, they showed
similar reduced regulatory responses compared to CD45RO+ adult
Treg cells (Fujimaki et al., 2008). Taking into account that most of the
Treg cells in our study children have a naive phenotype (Fig. S3), this
could explain why the ALK5i treatment did not reveal a higher
frequency of IFN-γ+ CD4+ T cells in response to RV (Fig. 5C). It is
important to note that the regulatory function of cord blood Treg cells
becomes more apparent in assays in which effector responses are
evaluated to strong stimulus such as polyclonal ones (Chang et al.,
2005; Thornton et al., 2004); this observation could explain the
increments in the frequencies of IFN-γ+ CD4+ T cells in response to
SEB in some children (Fig S2).
Lack of detection of RV-T cells in children is intriguing, because 75%
of them have antigenemia (Table S1) and for this reason, one would
expect at least a systemic T cell response. Of note, the few children
from group C with IFN-γ+ RV-CD4+ T cells (Fig. 3) response are
equally distributed among children with and without antigenemia
(data not shown). Other studies are necessary to clarify why RV
speciﬁc T cells are so low in children with RV GE; and especially, to
explore the local immune response to RV in the human GALT.
In conclusion, our results show that in healthy adults RV-CD4+
T cells predominantly produce IFN-γ+ and not IL-2, and that IFN-γ+
CD4+ and to a lesser extent CD8+ T cells are modulated by CD25+
Treg cells and by a TGF-β-dependent regulatory mechanism (inde-
pendent from CD25+ Treg cells). In contrast, children with acute
RV GE have few or no circulating RV-T cells and regulation by TGF-β
cannot explain this ﬁnding.
Materials and methods
Subjects and specimen collection
Three groups of individuals were enrolled in this study: healthy
adult volunteers (H) (n=21; 11 female and 10 male; median
age=26 years, range: 20–49), adults with acute RV GE (n=5; 4
female and 1 male; median age=22 years; range: 21–34) and
children with diarrhea (n=53; 14 females and 39 males; median
age=14 months; range: 4–22). Healthy adult volunteers and adults
with RV GE were students from the Medical School and hospital or
laboratory employees; adults with GE were studied during the acute
(A) (1–7 days after onset of symptoms) and convalescence (C)
(12–35 days after onset of symptoms) phases of the disease. Children
with diarrheawere hospitalized at themoment of sample collection in
the San Ignacio Hospital. All adult volunteers and parents or guardiansof children signed an informed consent approved by the Ethics
Committee of the Medical School of the Pontiﬁcia Universidad
Javeriana. Peripheral blood samples were drawn with heparin and
EDTA anticoagulants. Stool samples were collected from patients with
diarrhea and stored at−70 °C. Blood samples with EDTAwere used to
obtain complete blood counts while samples with heparin were
centrifuged at 400×g for 10 min to obtain plasma and cells. Plasma
samples were stored at −70 °C and cells were diluted 1:3 with
phosphate buffer solution (PBS; pH=7.4; Cellgro, Lawrence, KS) to
isolate PBMC using Lymphosep medium (d=1.077; ICN Biomedical
Inc. Irvine, CA). PBMC were washed twice with AIM-V media, (Gibco,
Grand Island, NY) and used fresh in all experiments.
Detection of RV antigen, RV RNA and RV speciﬁc IgA
The presence of RV antigen in feces was determined using an ELISA
previously described (Jaimes et al., 2002). A supernatant of the RF
(P6[1]G6) strain of bovine RV-infected MA104 cells was used as a
positive control and a known RV negative human fecal specimen was
used as a negative control in each plate. Results were expressed as
percentage of reactivity referred to the positive control. From all stool
samples nucleic acids were extracted and RV P genotyping was
performed as previously described (Mesa et al., 2007; Rojas et al.,
2007). Plasma RV-speciﬁc IgA was detected by ELISA as previously
described (Rojas et al., 2003) deﬁning the titer of plasma IgA as the
reciprocal of the last dilution exceeding an optical density of 0.1 that
was twice the optical density of mock-treated wells. For detection of
RV antigen in plasma, the same protocol described for feces was
followed, with minor modiﬁcations: plasma samples were diluted in
Blotto 2.5% and non diluted PBMC lysates were used (Crawford et al.,
2006), and three instead of ﬁve washes were made; the RV antigen
level was expressed as percentage of reactivity referred to the positive
control.
Viruses and cells
The RRV strain (P5B[3] G3) of simian RV (obtained from Dr. H.B.
Greenberg, Stanford University, CA) was grown in MA104 cells as
previously described (Mesa et al., 2007). When RRV was used as a
clariﬁed MA104 cells culture supernatant (titre of 3.5×107 focus
forming units [ffu]/ml) the supernatant of mock-infectedMA104 cells
was used as a control. RRV puriﬁed on a CsCl gradient was obtained as
previously described (Mesa et al., 2007) and had titres between 3 and
8×107 ffu/ml. Before use, puriﬁed virus was dialyzed against RPMI
(Gibco-BRL, Gaithersburg, MD) and the dialyzing media was kept to
be used as control. For some experiments, the Wa strain (P1A[8] G1)
of human RV (obtained from Dr. E. Mendez, UNAM, Mexico) was
treated with 3 μg/ml trypsin (Sigma, St. Louis, MO) for 45 min at 37 °C
and then grown in MA104 for 16 h at 37 °C. Cells were lysed by
repeated freezing and thawing and then concentrated on a 40%
sucrose cushion. The Wa stocks had titres between 2 and 3×108
ffu/ml. Supernatants of MA104 cells cultured without Wa and treated
similarly were used as mock controls. The RNA patterns of both RV
strains were conﬁrmed by polyacrylamide gel electrophoresis.
Quantiﬁcation of leukocytes and of Treg subpopulations
Absolute counts of total and subsets of leukocytes were deter-
mined using the Coulter hematology analyzers STKS or LH750. Two
protocols were used for quantiﬁcation and phenotyping of Treg cells
and all monoclonal antibodies (MAbs) were from BD Biosciences (San
Diego, CA) except where indicated. In the ﬁrst protocol (stain 1),
PBMC were stained with biotinylated goat anti-human LAP (TGF-β1)
polyclonal Ab (R&D Systems; Minneapolis, MN) or with control
biotinylated goat IgG (R&D Systems) at 4 °C for 30 min. After washing
with staining buffer (0.5% bovine serum albumin [Merck, KGaA,
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Paris, KY] in PBS) cells were stained with anti-CD4 FITC, anti-CD25
APC, anti-CD127 PE MAbs and PerCP conjugated Streptavidin for
30 min at 4 °C. Cells were washed and resuspended in 1%
paraformaldehyde in PBS. Cells were acquired with a FACSCalibur
ﬂow cytometer (BD Biosciences) equipped with blue and red lasers
and analysed with CellQuest Pro software. Dead cells and debris were
excluded by forward and side scatter gating. Results are expressed as
relative and absolute counts of CD4+CD25+, CD4+CD25+CD127low,
and CD4+CD25+CD127lowLAP+ T cells (Fig. S3A). For the second
protocol (stain 2), PBMC were washed with PBS and resuspended in
400 μl Aqua viability reagent (25 μg/ml Aqua [Invitrogen Molecular
Probes, Eugene, OR] in PBS) for 30 min at 4 °C. Then cells were
washed, FCγRs were blocked with 5 μl FCγR blocking reagent
(Miltenyi Biotec Inc, Auburn CA) for 15 min at room temperature,
and then stained with anti-CD3 Paciﬁc Blue, anti-CD4 PerCPCy5.5,
anti-CD25 APC, anti-CD45RA PECy7, anti-CD127 FITC (eBioscience,
San Diego CA) and anti-LAP PE (R&D systems) or IgG1 isotype control-
PE MAb (R&D Systems). Cells were incubated for 45 min at 4 °C,
washedwith staining buffer, acquired in a FACSAriaﬂowcytometer (BD
Biosciences) equipped with blue, red and violet lasers and analysed
with FlowJo v.7.4 software. Results are expressed as relative and abso-
lute counts of viable CD3+CD4+CD25+, CD3+CD4+CD25+CD127low,
and CD3+CD4+CD25+CD127lowLAP+ T (Fig. S3B).
Depletion of CD25+ cells
CD25+-depletedPBMCwere obtainedusingMACSCD25MicroBeads
(Miltenyi Biotec Inc) following the protocol previously described
(Aandahl et al., 2004). To verify that CD25+ cells were correctly
removed, fractions of cells were stained before and after the depletion
process. The fractions of CD4+CD25int and CD4+CD25hi cells removed
were 61% or higher and 100%, respectively.
Inhibition of TGF-β activity
To block the activity of TGF-β, previously tittered 12 μg/ml
recombinant human latent associated peptide (rhLAP) (R&D Systems)
or 10 μM SB431542 (TGF-βRI/ALK5 inhibitor; ALK5i; Sigma or Tocris,
Ellisville, MO) were added to the PBMC for 10 min and 30 min,
respectively, at 37 °C before antigen stimulation.
Culture of PBMC and intracellular cytokine staining (ICS)
To evaluate the frequency of cytokine producing T cells, ICS was
performed, as previously described (Jaimes et al., 2002). In this short
term assay, only memory T cells have the capacity to respond and
thus are the only cells detected. Brieﬂy, 1×106/ml total PBMC were
incubated with RV (RRV or Wa) (MOI=7), control supernatant
(mock) or 1.25 μg/ml superantigen, Staphylococcal enterotoxin B
(SEB) (Sigma), in the presence of 0.5 μg/ml anti-CD49d MAb (BD
Pharmingen) and 0.5 μg/ml anti-CD28 MAb (BD Pharmingen) for
10 h at 37 °C. For the last 5 h, 5.0 μg/ml Brefeldin A (Sigma) was
added. The human RV strain, Wa (MOI=7), was used in selected
experiments to conﬁrm the results with RRV. Cells were washed with
PBS and 0.05 mM EDTA in PBS, ﬁxed with 1% paraformaldehyde in
PBS and then treated with FACS Permeabilizing Solution 2 (BD
Biosciences). Then cells were stained for 30 min at 4 °C with FITC, PE,
PECy7, PerCP, PerCP-Cy5.5, APC, APC-Cy7 or Paciﬁc Blue-conjugated
mouse MAbs to CD3, CD4, CD8, CD69, IFN-γ, IL-13, IL-10, IL-2 and
IL-17. Cells were washed and resuspended in 1% paraformaldehyde
in PBS, acquired on FACSCalibur or FACSAria Flow Cytometers (BD
Biosciences) and analyzed with Cell Quest Pro, DIVA v.6.1 or FlowJo
v.7.4 softwares. Results are reported as net percentage of cytokine
positive, CD69+CD4+ or CD69+CD8+ cells after subtracting the
values observed with cells stimulated with control antigens, whichshowed values with a median of 0.017%. Net values greater than
0.02% were considered positive for all cytokine producing T cells,
according to the values observed in children without evidence of
exposure to RV (group A children, see below). Due to limited amount
of cells recovered from children and some adults, not all experiments
were performed with cells from each individual. For this reason
numbers of subjects vary between the different tables and ﬁgures.
Statistical analysis
Statistical analyses were performedwith GraphPad Prism software
v.5.0, using non-parametric tests. Differences between non-paired
and paired results were compared with Mann–Whitney U tests and
Wilcoxon tests, respectively. Kruskall–Wallis was used to determine
differences among several groups followed by Mann–Whitney test to
compare two groups. Chi square and Fisher exact tests were used for
comparison of frequencies. Signiﬁcance was established if Pb0.05.
Data are shown as median and range.
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